Access to subsidised treatment of uncomplicated urinary tract infections and hormonal contraceptives will be expanded.
Current use of hormonal contraception for birth control, compared with never use, among women younger than 40 years is significantly associated with a 22-fold higher prevalence of recurrent UTIs.